Target intelligence / Profile preview

ATP synthase membrane subunit j, mitochondrial (ATP5MJ)

Target
ATP5MJ
Molecular classification
Enzyme complex subunit, Mitochondrial membrane protein, Component of ATP synthase (Complex V), Other
01

Overview

ATP synthase membrane subunit j, mitochondrial (ATP5MJ) is a small, integral membrane protein that is a component of the F0 complex of mitochondrial ATP synthase (Complex V)[1]. It plays a role in ATP production by participating in the rotary mechanism that couples proton translocation across the mitochondrial membrane to ATP synthesis in the F1 catalytic domain[1][2]. ATP5MJ is necessary for maintaining the overall ATP synthase population within mitochondria and, through this, is essential for normal cellular bioenergetics. Mutations or deficiencies in ATP5MJ may be associated with mitochondrial dysfunction and linked to diseases such as streptococcal meningitis and cone-rod dystrophy[1]. As a subunit of a fundamental energy-generating enzyme complex, it is not commonly a direct therapeutic target, but can be affected by inhibitors of the whole ATP synthase, such as oligomycin[3]. Because of its essential role in mitochondrial energy metabolism, it is highly conserved and critical for cell viability[1].

Other names
ATP5MPLC14orf2MP68PRO1574MLQ6.8PL6.8 kDa mitochondrial proteolipid proteinATP synthase membrane subunit 6.8PL6.8 kDa mitochondrial proteolipid6.8-kDa proteolipid with N-terminal sequence Met-Leu-GlnPLPM
02

Mechanism of action

Inhibition of ATP synthase by blocking proton translocation (for drugs like oligomycin that target the F0 domain, which includes membrane subunits)

03

Biological functions

ATP synthesisMitochondrial energy productionMaintenance of mitochondrial ATP synthase population
04

Disease associations

Streptococcal meningitisCone-rod dystrophyOther neurodegenerative or mitochondrial diseases (potential, based on function)
05

Safety considerations

Systemic inhibition affects cellular ATP production, potentially leading to multi-organ dysfunctionmitochondrial toxicity risk
06

Interacting drugs

Oligomycin (general ATP synthase inhibitor, not selective for j subunit)

Beyond the preview

Go deeper on ATP synthase membrane subunit j, mitochondrial (ATP5MJ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ATP synthase membrane subunit j, mitochondrial (ATP5MJ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call